started · updated
Ghana develops framework to boost local pharmaceutical manufacturing
Ghana’s Food and Drugs Authority (FDA) has introduced a new framework to guide investors in establishing pharmaceutical factories. This initiative is part of a government strategic plan to increase local medicine production from approximately 30% to between 60% and 70% of national needs.
Under the new framework, investors must complete construction, equipment installation, qualification, process validation, and non-commercial trial batches before applying for a Good Manufacturing Practice (GMP) license. Dr. George Sabblah, Deputy CEO of the FDA, stated that this pathway aims to reduce regulatory uncertainty and provide a predictable route for new facilities.
Regulatory expert Benjamin Botwe has also called for the development of local capacity to produce active pharmaceutical ingredients (APIs). He noted that Ghana currently produces no pharmaceutical raw materials, vaccines, or medical devices, leaving the country heavily dependent on imports. Botwe emphasized that achieving true health sovereignty requires moving beyond the packaging of imported chemicals to the actual synthesis of essential ingredients.
Entities
Benjamin Botwe · Food and Drugs Authority · George Sabblah · Ghana · University of Health and Allied Sciences